Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Discovery, preclinical and clinical activity of INCB-018424 described

Dec. 11, 2007

Further data presented on rotigotine patch efficacy in restless legs syndrome

Dec. 11, 2007

KNS-760704 doses up to 300 mg safe in healthy volunteers

Dec. 10, 2007

Possible effect on survival seen with AL-02 in amyotrophic lateral sclerosis

Dec. 10, 2007

Preclinical studies shed light on the activity of ofatumumab in B-cells

Dec. 10, 2007

Stem cell transplant plus T-cells with bispecific antibody studied in lymphoma

Dec. 10, 2007

KW-0761 investigated in phase I study in lymphoma patients

Dec. 10, 2007

Rasagiline may slow deterioration of amyotrophic lateral sclerosis

Dec. 7, 2007

Treatment effects and cardiovascular safety of dapoxetine assessed in phase III study

Dec. 7, 2007

Mirodenafil significantly improves erectile dysfunction in double-blind study

Dec. 7, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...